Heat Biologics raised $5 million in its latest round of equity funding. The firm, based in Chapel Hill, N.C., will use the money to support clinical trials of its lung cancer and bladder cancer drugs.
Published in Brief:
|Senior Director, Biostatistics||
|Associate - Food and Drug||
Keller and Heckman LLP
|Senior Paralegal - Research & Development, and Medical||